Lincoln Pharmaceuticals Limited Stock NSE India S.E.

Equities

LINCOLN

INE405C01035

Pharmaceuticals

Delayed NSE India S.E. 05:24:03 2024-04-23 am EDT 5-day change 1st Jan Change
599.8 INR +1.54% Intraday chart for Lincoln Pharmaceuticals Limited +3.28% -1.58%
Sales 2022 4.72B 56.66M Sales 2023 5.1B 61.24M Capitalization 6.78B 81.42M
Net income 2022 694M 8.33M Net income 2023 729M 8.75M EV / Sales 2022 1.08 x
Net cash position 2022 1.14B 13.63M Net cash position 2023 1.12B 13.42M EV / Sales 2023 1.11 x
P/E ratio 2022
8.98 x
P/E ratio 2023
9.31 x
Employees 1,645
Yield 2022
0.48%
Yield 2023
0.44%
Free-Float 44.04%
More Fundamentals * Assessed data
Dynamic Chart
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director CI
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23 CI
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023 CI
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer CI
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22 CI
More news
1 day+1.54%
1 week+3.28%
Current month+2.35%
1 month-1.01%
3 months-9.39%
6 months+24.36%
Current year-1.58%
More quotes
1 week
565.10
Extreme 565.1
599.85
1 month
558.30
Extreme 558.3
623.00
Current year
555.00
Extreme 555
755.15
1 year
365.25
Extreme 365.25
755.15
3 years
249.45
Extreme 249.45
755.15
5 years
85.05
Extreme 85.05
755.15
10 years
85.05
Extreme 85.05
755.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 95-01-19
Director of Finance/CFO - 19-03-27
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 70 95-01-19
Chairman 80 95-08-15
Director/Board Member 66 95-01-19
More insiders
Date Price Change Volume
24-04-23 599.8 +1.54% 27 071
24-04-22 590.8 +1.49% 27,001
24-04-19 582.1 +0.38% 41,688
24-04-18 579.9 -0.15% 24,450
24-04-16 580.8 +0.57% 37,207

Delayed Quote NSE India S.E., April 23, 2024 at 05:24 am EDT

More quotes
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceuticals products like medicines, injections and other related products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid in bott, liquid injection and pharma products. It has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.
More about the company